Scientific Review Officer at National Heart, Lung, and Blood Institute
Location:
Bethesda, Maryland
Industry:
Government Administration
Work:
National Heart, Lung, and Blood Institute since Nov 2010
Scientific Review Officer
NYU School of Medicine Apr 1998 - Oct 2010
Assistant Professor
NYU Medical Center Feb 1992 - Mar 1998
Post-Doctoral Research Fellow
Education:
Università degli Studi di Bari 1989
PhD, Medical Biochemistry
Istituto Mario Negri, Milano (Italy) 1985 - 1987
Universita' degli Studi di Bari 1983
Master of Science (MS), Biology
Us Patents
Inhibition Of Mitogen-Activated Protein Kinases In Cardiovascular Disease
Aubrey Galloway - Bronxville NY, US Paolo Mignatti - New York NY, US Giuseppe Pintucci - Tuckahoe NY, US
Assignee:
New York University - New York NY
International Classification:
A61K 38/48 A61F 2/00
US Classification:
424094500, 424426000
Abstract:
The present invention relates to methods for inhibiting subacute thrombosis and/or intimal hyperplasia following an interventional vascular procedure by contacting a blood vessel or a synthetic material with a mitogen-activated protein kinase (MAPK) pathway inhibitor. The present invention further relates to vascular devices comprising a MAPK pathway inhibitor.
Inhibition Of Mitogen-Activated Protein Kinases In Cardiovascular Disease
Aubrey Galloway - Bronxville NY, US Paolo Mignatti - New York NY, US Giuseppe Pintucci - Tuckahoe NY, US
Assignee:
New York Universtiy - New York NY
International Classification:
A61K 31/135 A61P 9/00
US Classification:
514646
Abstract:
The present invention relates to methods for inhibiting subacute thrombosis and/or intimal hyperplasia following an interventional vascular procedure by contacting a blood vessel or a synthetic material with a mitogen-activated protein kinase (MAPK) pathway inhibitor. The present invention further relates to vascular devices comprising a MAPK pathway inhibitor.
Inhibition Of Mitogen-Activated Protein Kinases In Cardiovascular Disease
NEW YORK UNIVERSITY - New York NY, US Paolo Mignatti - New York NY, US Giuseppe Pintucci - Tuckahoe NY, US
Assignee:
NEW YORK UNIVERSITY - New York NY
International Classification:
A61K 31/4439 A61M 25/10 A61K 45/00
US Classification:
514341, 604509
Abstract:
The present invention relates to methods for inhibiting subacute thrombosis and/or intimal hyperplasia following an interventional vascular procedure by contacting a blood vessel or a synthetic material with a mitogen-activated protein kinase (MAPK) pathway inhibitor. The present invention further relates to vascular devices comprising a MAPK pathway inhibitor.